Authors:
Dimopoulos, MA
Zervas, K
Kouvatseas, G
Galani, E
Grigoraki, V
Kiamouris, C
Vervessou, E
Samantas, E
Papadimitriou, C
Economou, O
Gika, D
Panayiotidis, P
Christakis, I
Anagnostopoulos, N
Citation: Ma. Dimopoulos et al., Thalidomide and dexamethasone combination for refractory multiple myeloma, ANN ONCOL, 12(7), 2001, pp. 991-995
Authors:
Zervas, K
Pouli, A
Gregoraki, B
Anagnostopoulos, N
Dimopoulos, MA
Bourantas, K
Tzilianos, M
Barbarousi, D
Venetis, E
Vyniou, N
Maniatis, A
Citation: K. Zervas et al., Comparison of vincristine, carmustine, melphalan, cyclophosphamide, prednisone (VBMCP) and interferon-alpha with melphalan and prednisone (MP) and interferon-alpha (IFN-alpha) in patients with good-prognosis multiple myeloma: a prospective randomized study, EUR J HAEMA, 66(1), 2001, pp. 18-23
Authors:
Araten, DJ
Swirsky, D
Karadimitris, A
Notaro, R
Nafa, K
Bessler, M
Thaler, HT
Castro-Malaspina, H
Childs, BH
Boulad, F
Weiss, M
Anagnostopoulos, N
Kutlar, A
Savage, DG
Maziarz, RT
Jhanwar, S
Luzzatto, L
Citation: Dj. Araten et al., Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria, BR J HAEM, 115(2), 2001, pp. 360-368
Authors:
Zomas, A
Anagnostopoulos, N
Dimopoulos, MA
Citation: A. Zomas et al., Successful treatment of multiple myeloma relapsing after high-dose therapyand autologous transplantation with thalidomide as a single agent, BONE MAR TR, 25(12), 2000, pp. 1319-1320
Authors:
Thodou, E
Kontogeorgos, G
Kyrodimou, E
Salla, H
Ramyar, L
Vamvassakis, E
Piaditis, G
Anagnostopoulos, N
Tzanis, S
Levedis, A
Rologis, D
Asa, SL
Citation: E. Thodou et al., Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: An in vitro study with the reverse hemolytic plaque assay, J ENDOC INV, 22(9), 1999, pp. 671-680